@article{b21d8ad1e136447fa4d39b4b9198c037,
title = "Moving to fingolimod from natalizumab in multiple sclerosis: the ENIGM is not solved",
abstract = "Moving to fingolimod from natalizumab in multiple sclerosis-reply",
keywords = "Antibodies, Monoclonal, Humanized, Drug Substitution, Female, Humans, Immunosuppressive Agents, Male, Multiple Sclerosis, Propylene Glycols, Sphingosine, Antibodies, Monoclonal, Humanized, Drug Substitution, Female, Humans, Immunosuppressive Agents, Male, Multiple Sclerosis, Propylene Glycols, Sphingosine",
author = "Assunta Bianco and Rossini, {Paolo Maria} and Massimiliano Mirabella",
year = "2014",
doi = "10.1001/jamaneurol.2014.1135",
language = "English",
volume = "71",
pages = "924--925",
journal = "JAMA Neurology",
issn = "2168-6149",
publisher = "American Medical Association",
}